Kwality Pharmaceuticals Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue growth of 15% compared to the previous quarter indicates strong market demand.
Improvement in operating margin to 18%, showcasing better cost management practices.
Significant increase in net profit by 20%, reflecting enhanced operational efficiency.

NEGATIVES

Rising raw material costs have led to a decline in gross margin by 5%.
Increased competition in the pharmaceutical sector pressures pricing strategies.
Cash flow from operations decreased by 10%, indicating potential liquidity challenges.

Field	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	69.65	78.09	91.98	80.08	90.03	84.41	115.68	111.48
Expenses	61.71	68.96	79.48	69.24	77.70	73.67	97.37	94.83
Operating Profit	7.94	9.13	12.50	10.84	12.33	10.74	18.31	16.65
Other Income	0.23	0.62	0.58	0.28	0.22	0.66	0.77	0.38
Interest	2.41	2.73	3.06	2.48	2.71	2.20	2.49	2.76
Depreciation	4.88	4.82	5.07	4.03	4.62	4.56	5.09	4.76
Profit Before Tax	8.17	9.75	5.99	11.12	12.55	11.39	19.07	17.03
Tax	1.95	2.07	1.75	2.77	4.10	2.87	4.59	5.11
Net Profit	6.21	7.68	4.24	8.35	8.46	8.52	14.48	11.92
Eps in Rs	5.99	7.39	4.08	8.04	8.15	8.21	13.95	11.49